share_log

Iterum Therapeutics | 8-K: Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

SEC ·  Mar 29 19:16
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.